Affiliation:
1. School of pharmaceutical sciences, Nanjing Tech University, No. 30 South Puzhu Road, Nanjing 211816, China
2. College of Biotechnology and pharmaceutical Engineering, Nanjing Tech University, No. 30 South Puzhu Road, Nanjing 211816, China
Abstract
:
Malaria is one of the three most deadly infectious diseases in the world and
seriously endangers human health and life. To reduce the public health burden of this
disease, scientists have focused on the discovery and development of effective
antimalarial drugs, from quinine and chloroquine to antifolates and artemisinin and its
derivatives, which all play a profound role in the treatment of malaria. However, drugresistant
strains of Plasmodium falciparum have emerged due to frequent use of
antimalarials and have become increasingly resistant to existing antimalarial drugs,
causing disastrous consequences in the world. In particular, artemisinin resistance is of
greatest concern which was reported in 2008. Resistance to artenisinins has been a
major obstacle for malaria control, and current efforts to curb artemisinin resistance have
not been successful. Based on the current situation, it is urgent to develop more effective
new antimalarials with distinct targets from conventional antimalarials in the world, which
could facilitate to minimize the phenomenon of drug resistance. This review aims to
summarize different kinds of antimalarial therapeutic efficacy, mechanisms of action and
resistance, and proposes new solutions aiming towards further improvement of malaria
elimination.
Publisher
Bentham Science Publishers Ltd.
Subject
Molecular Biology,Molecular Medicine,General Medicine,Biochemistry
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献